PathMaker Neurosystems Announces Issuance of 3 Patents

“We are pleased to see these latest patent issuances that protect PathMaker’s novel technology for the non-invasive treatment of ALS,” said Jake Maslow, J.D., Co-Founder and Chief Intellectual Property Officer at PathMaker. “These patents provide additional protection specific to the treatment of ALS that goes beyond the more than 40 issued patents we already have protecting our platform globally.”